What is ResMed's AOCI?

ResMed (RMD) reported AOCI of -$24.91M in Q1 2026.

How has ResMed's AOCI changed year-over-year?

ResMed's AOCI increased by 90.1% year-over-year, from -$250.86M to -$24.91M.

What is the long-term trend for ResMed's AOCI?

Over 4 years (2021 to 2025), ResMed's AOCI has grown at a -21.2% compound annual growth rate (CAGR), from -$193.49M to -$74.7M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

ResMed RMD AOCI

AOCI at other companies

Eli LillyLLY

-$2.83B+24.9%

InogenINGN

$3.42M+768%

Five Point Holdings, Inc.FPH

-$1.55M-5.9%

Inspire Medical SystemsINSP

-$352K-255%

LivaNovaLIVN

-$3.4M+92.0%

Pulmonx CorporationLUNG

$2.17M-1.5%

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$28.27B-19.1%

Enterprise value$27.71B-19.8%

P/E18.6×-6.3×

P/S5.1×-1.7×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's AOCI?: ResMed (RMD) reported AOCI of -$24.91M in Q1 2026.
How has ResMed's AOCI changed year-over-year?: ResMed's AOCI increased by 90.1% year-over-year, from -$250.86M to -$24.91M.
What is the long-term trend for ResMed's AOCI?: Over 4 years (2021 to 2025), ResMed's AOCI has grown at a -21.2% compound annual growth rate (CAGR), from -$193.49M to -$74.7M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.